<header id=034929>
Published Date: 2022-03-04 14:30:00 EST
Subject: PRO/ALL> New in IJID (03): March 2022
Archive Number: 20220304.8701795
</header>
<body id=034929>
NEW IN INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (03): MARCH 2022
********************************************************************
A ProMED-mail post
http://www.promedmail.org
ProMED-mail is a program of the
International Society for Infectious Diseases
http://www.isid.org

Date: February 2022
Source: IJID [edited]
https://www.ijidonline.com/


Coronavirus (COVID-19) collection
---------------------------------
Perspective
-----------
Should we recommend remdesivir in an early stage of COVID-19
Martinot et al.
Int J Infect Dis. 2022; 116: 281-2
https://doi.org/10.1016/j.ijid.2021.12.359

Reviews
-------
Clinical significance of hepatosplenic thrombosis in vaccine-induced immune thrombotic thrombocytopenia after ChAdOx1 nCoV-19 vaccination: a systematic review
Hwang et al.
Int J Infect Dis. 2022; 116: 114-21
https://doi.org/10.1016/j.ijid.2021.12.352

Characteristics analysis for clinical study design relating to COVID-19 based on the database of ClinicalTrials.gov
Wu et al.
Int J Infect Dis. 2022; 116: 210-5
https://doi.org/10.1016/j.ijid.2022.01.015

Clinical
--------
Decreased severity of disease during the first global omicron variant COVID-19 outbreak in a large hospital in Tshwane, South Africa
Abdullah et al.
Int J Infect Dis. 2022; 116: 38-42
https://doi.org/10.1016/j.ijid.2021.12.357

Viral co-pathogens in COVID-19 acute respiratory syndrome -- what did we learn from the first year of pandemic?
Kriger et al.
Int J Infect Dis. 2022; 116: 226-9
https://doi.org/10.1016/j.ijid.2022.01.018

Symptoms experienced at the acute phase of SARS-CoV-2 infection as risk factor of long-term post-COVID symptoms: the LONG-COVID-EXP-CM multicenter study
Fernández-de-las-Peñas et al.
Int J Infect Dis. 2022; 116: 241-4
https://doi.org/10.1016/j.ijid.2022.01.007

Long-term detection of SARS-CoV-2 antibodies after infection and risk of re-infection
Langhoff Hønge et al.
Int J Infect Dis. 2022; 116: 289-92
https://doi.org/10.1016/j.ijid.2022.01.041

Hypersensitivity reaction to hyaluronic acid dermal filler after COVID-19 vaccination: a series of cases in São Paulo, Brazil
Prestes-Carneiro et al.
Int J Infect Dis. 2022; 116: 268-70
https://doi.org/10.1016/j.ijid.2022.01.024

COVID-19 pneumonia patients with 25(OH)D levels lower than 12 ng/ml are at increased risk of death
Smaha et al.
Int J Infect Dis. 2022; 116: 313-8
https://doi.org/10.1016/j.ijid.2022.01.044

Hypothyroidism does not lead to worse prognosis in COVID-19: findings from the Brazilian COVID-19 registry
Pereira et al.
Int J Infect Dis. 2022; 116: 319-27
https://doi.org/10.1016/j.ijid.2022.01.016

Severe outcomes, readmission, and length of stay among COVID-19 patients with intellectual and developmental disabilities
Koyama et al.
Int J Infect Dis. 2022; 116: 328-30
https://doi.org/10.1016/j.ijid.2022.01.038

Diagnostics
-----------
A pooled RT-PCR testing strategy for more efficient COVID-19 pandemic management
Ayaz et al.
Int J Infect Dis. 2022; 116: 1-6
https://doi.org/10.1016/j.ijid.2021.12.328

Performance of colorimetric RT-LAMP as a diagnostic tool for SARS-CoV-2 infection during the fourth wave of COVID-19 in Thailand
Promlek et al.
Int J Infect Dis. 2022; 116: 133-7
https://doi.org/10.1016/j.ijid.2021.12.351

Diagnostic performance, user acceptability, and safety of unsupervised SARS-CoV-2 rapid antigen detecting tests performed at home
Møller et al.
Int J Infect Dis. 2022; 116: 358-64
https://doi.org/10.1016/j.ijid.2022.01.019

Treatment
---------
Influence of chronic corticosteroids and calcineurin inhibitors on COVID-19 clinical outcomes: analysis of a nationwide registry
Calderón-Parra et al.
Int J Infect Dis. 2022; 116: 51-8
https://doi.org/10.1016/j.ijid.2021.12.327

Evaluation of reporting quality of abstracts of randomized controlled trials regarding patients with COVID-19 using the CONSORT statement for abstracts
Yin et al.
Int J Infect Dis. 2022; 116: 122-9
https://doi.org/10.1016/j.ijid.2022.01.002

Predictive risk factors for hospitalization and response to colchicine in patients with COVID-19
Tardif et al.
Int J Infect Dis. 2022; 116: 387-90
https://doi.org/10.1016/j.ijid.2022.01.020

Effective presence of antibodies against common human coronavirus in IgG immunoglobulin medicinal products
Diez et al.
Int J Infect Dis. 2022; 116: 68-73
https://doi.org/10.1016/j.ijid.2021.12.329

Immunology and pathophysiology
------------------------------
Low transferrin levels predict heightened inflammation in COVID-19 patients: new insights
Claise et al.
Int J Infect Dis. 2022; 116: 74-79
https://doi.org/10.1016/j.ijid.2021.12.340

Proteomic profiling reveals a distinctive molecular signature for critically ill COVID-19 patients compared with asthma and COPD
Zhang et al.
Int J Infect Dis. 2022; 116: 258-67
https://doi.org/10.1016/j.ijid.2022.01.008

Persistence of clinically-relevant levels of SARS-CoV2 envelope gene subgenomic RNAs in non-immunocompromised individuals
Davies et al.
Int J Infect Dis. 2022; 116: 418-25
https://doi.org/10.1016/j.ijid.2021.12.312

Vaccines
--------
Comparing self-reported reactogenicity between adolescents and adults following the use of BNT162b2 (Pfizer-BioNTech) messenger RNA COVID-19 vaccine: a prospective cohort study
Chan et al.
Int J Infect Dis. 2022; 116: 47-50
https://doi.org/10.1016/j.ijid.2021.12.354

Effectiveness of inactive COVID-19 vaccines against severe illness in B.1.617.2 (delta) variant-infected patients in Jiangsu, China
Hu et al.
Int J Infect Dis. 2022; 116: 204-9
https://doi.org/10.1016/j.ijid.2022.01.030

Epidemiology
------------
Seroprevalence of IgG antibodies against SARS-CoV-2 in India, March 2020-August 2021: a systematic review and meta-analysis
Jahan et al.
Int J Infect Dis. 2022; 116: 59-67
https://doi.org/10.1016/j.ijid.2021.12.353

Genomic characterization of SARS-CoV-2 and its association with clinical outcomes: a one-year longitudinal study of the pandemic in Colombia
Ruiz-Sternberg et al.
Int J Infect Dis. 2022; 116: 91-100
https://doi.org/10.1016/j.ijid.2021.12.326

Community seroprevalence and risk factors for SARS CoV-2 infection in different subpopulations in Vellore, India and its implications for future prevention
Dayanand et al.
Int J Infect Dis. 2022; 116: 138-46
https://doi.org/10.1016/j.ijid.2021.12.356

SARS-CoV-2 prevalence and immunity: a hospital-based study from Malawi
Meinus et al.
Int J Infect Dis. 2022; 116: 157-65
https://doi.org/10.1016/j.ijid.2021.12.336

SARS-CoV-2 infection in children in Moscow in 2020: clinical features and impact on circulation of other respiratory viruses
Yakovlev et al.
Int J Infect Dis. 2022; 116: 331-8
https://doi.org/10.1016/j.ijid.2021.12.358

Mortality by COVID-19 prior to vaccination -- one year experience of hospitalized patients in Madrid
Moreno-Torres et al.
Int J Infect Dis. 2022; 116: 339-43
https://doi.org/10.1016/j.ijid.2022.01.043

Secondary transmission of SARS-CoV2 during the first two waves in Japan: demographic characteristics and overdispersion
Ko et al.
Int J Infect Dis. 2022; 116: 365-73
https://doi.org/10.1016/j.ijid.2022.01.036

A cluster of SARS-CoV-2 delta variant of concern additionally harboring F490S, northern Lombardy, Italy
Novazzi et al.
Int J Infect Dis. 2022; 116: 271-2
https://doi.org/10.1016/j.ijid.2021.12.362

Public health
-------------
Considerations for COVID-19 management in reception centers for refugees, asylum seekers and migrants, Spain 2020
Hoefer et al.
Int J Infect Dis. 2022; 116: 108-10
https://doi.org/10.1016/j.ijid.2021.12.341

The role of institutional, cultural, and economic factors on the effectiveness of the lockdown measures
Çakmaklı et al.
Int J Infect Dis. 2022; 116: 111-3
https://doi.org/10.1016/j.ijid.2021.12.333

Safety and tolerability of hydroxychloroquine in health care workers and first responders for the prevention of COVID-19 WHIP COVID-19 Trial
McKinnon et al.
Int J Infect Dis. 2022; 116: 167-73
https://doi.org/10.1016/j.ijid.2021.12.343

Association of smoking and severity of COVID-19 infection among 5889 patients in Malaysia: a multi-centre observational study
Ismail et al.
Int J Infect Dis. 2022; 116: 189-96
https://doi.org/10.1016/j.ijid.2022.01.011

Reconstruction of the transmission chain of COVID-19 outbreak in Beijing's Xinfadi Market, China
Luo et al.
Int J Infect Dis. 2022; 116: 411-7
https://doi.org/10.1016/j.ijid.2022.01.035

Case reports
------------
A case of multisystem inflammatory syndrome in adults following natural infection and subsequent immunization
Lieu et al.
Int J Infect Dis. 2022; 116: 34-7
https://doi.org/10.1016/j.ijid.2021.12.339

The case of fatal acute hemorrhagic necrotizing encephalitis in a two-month-old boy with COVID-19
Mierzewska-Schmidt et al.
Int J Infect Dis. 2022; 116: 151-3
https://doi.org/10.1016/j.ijid.2021.12.334

Constrictive pericarditis after SARS-CoV-2 vaccination: a case report
Nakanishi et al.
Int J Infect Dis. 2022; 116: 238-40
https://doi.org/10.1016/j.ijid.2022.01.027

Case report: acute exacerbation of interstitial pneumonia related to mRNA COVID-19 vaccination
Amiya et al.
Int J Infect Dis. 2022; 116: 255-257
https://doi.org/10.1016/j.ijid.2022.01.031

Correspondence
--------------
Response to "Facial nerve palsy following the administration of COVID-19 mRNA vaccines: analysis of a self-reporting database" by Sato et al.
O'Fee et al.
Int J Infect Dis. 2022; 116: 10
https://doi.org/10.1016/j.ijid.2021.12.346

Comment on a case of pityriasis rosea shortly after Moderna COVID-19 vaccination
Drago et al.
Int J Infect Dis. 2022; 116: 166
https://doi.org/10.1016/j.ijid.2021.12.360

Non-COVID-19 collection
-----------------------
Perspectives
------------
A hot topic at the environment-health nexus: investigating the impact of climate change on infectious diseases
Grobusch et al.
Int J Infect Dis. 2022; 116: 7-9
https://doi.org/10.1016/j.ijid.2021.12.350

Reducing onchocerciasis-associated morbidity in onchocerciasis-endemic foci with high ongoing transmission: a focus on the young
Colebunders et al.
Int J Infect Dis. 2022; 116: 302-5
https://doi.org/10.1016/j.ijid.2022.01.042

Reviews
-------
Risk factors for types of recurrent tuberculosis (reactivation versus reinfection): a global systematic review and meta-analysis
Qiu et al.
Int J Infect Dis. 2022; 116: 14-20
https://doi.org/10.1016/j.ijid.2021.12.344

Clinical characteristics and an evaluation of predictors for a favorable outcome of _Mycobacterium abscessus_ otomastoiditis: a systematic review and meta-analysis of individual participant data
Manders et al.
Int J Infect Dis. 2022; 116: 397-402
https://doi.org/10.1016/j.ijid.2022.01.017

First-generation cephalosporins for the treatment of complicated upper urinary tract infection in adults: a systematic literature review
Daz-Brochero et al.
Int J Infect Dis. 2022; 116: 403-10
https://doi.org/10.1016/j.ijid.2021.12.363

Bacterial infections
--------------------
Bloodstream infections in hospitalized patients before and during the COVID-19 surge in a community hospital in the South Bronx
Afzal et al.
Int J Infect Dis. 2022; 116: 43-46
https://doi.org/10.1016/j.ijid.2021.12.349

mNGS for identifying pathogens in febrile neutropenic children with hematological disease
Guo et al.
Int J Infect Dis. 2022; 116: 85-90
https://doi.org/10.1016/j.ijid.2021.12.335

Optimizing cluster survey designs for estimating trachomatous inflammation-follicular within trachoma control programs
Gallini et al.
Int J Infect Dis. 2022; 116: 101-7
https://doi.org/10.1016/j.ijid.2021.12.355

Prognostic factors of _Pasteurella_ infections: a single-center retrospective cohort study over a 14-year period (2005-2018)
Dernoncourt et al.
Int J Infect Dis. 2022; 116: 197-203
https://doi.org/10.1016/j.ijid.2022.01.028

Risk factors for pneumococcal disease in persons with chronic medical conditions: results from the LIFE Study
Fukuda et al.
Int J Infect Dis. 2022; 116: 216-22
https://doi.org/10.1016/j.ijid.2021.12.365

Risk of post-treatment Lyme disease in patients with ideally-treated early Lyme disease: a prospective cohort study
Aucott et al.
Int J Infect Dis. 2022; 116: 230-7
https://doi.org/10.1016/j.ijid.2022.01.033

Evaluation of a syndromic panel polymerase chain reaction (spPCR) assay for the diagnosis of device associated bone and joint infections (BJI)
Berneking et al.
Int J Infect Dis. 2022; 116: 283-8
https://doi.org/10.1016/j.ijid.2022.01.013

Antimicrobial activity of high-dose cefepime-tazobactam (WCK 4282) against a large collection of gram-negative organisms collected worldwide in 2018 and 2019
Sader et al.
Int J Infect Dis. 2022; 116: 306-12
https://doi.org/10.1016/j.ijid.2022.01.029

Positive association between the use of macrolides in food-producing animals and pneumococcal macrolide resistance: a global ecological analysis
Kenyon et al.
Int J Infect Dis. 2022; 116: 344-7
https://doi.org/10.1016/j.ijid.2022.01.022

Induced sputum as an adequate clinical specimen for the etiological diagnosis of community-acquired pneumonia (CAP) in children and adolescents
Rueda et al.
Int J Infect Dis. 2022; 116: 348-54
https://doi.org/10.1016/j.ijid.2022.01.026

Tuberculosis and mycobacteria
-----------------------------
_Mycobacterium abscessus_ and _Mycobacterium massiliense_ exhibit distinct host and organ specificity: a cross-sectional study
Hsu et al.
Int J Infect Dis. 2022; 116: 21-6
https://doi.org/10.1016/j.ijid.2021.12.348

Pharmacokinetic features of dolutegravir with rifampicin and rifabutin among patients coinfected with human immunodeficiency virus and tuberculosis/mycobacterium avium complex
Le et al.
Int J Infect Dis. 2022; 116: 147-50
https://doi.org/10.1016/j.ijid.2022.01.001

Persistent dysglycemia is associated with unfavorable treatment outcomes in patients with pulmonary tuberculosis from Peru
Calderon et al.
Int J Infect Dis. 2022; 116: 293-301
https://doi.org/10.1016/j.ijid.2022.01.012

Viral infections
----------------
The impact of the COVID-19 preventive measures on influenza transmission: molecular and epidemiological evidence
Tran et al.
Int J Infect Dis. 2022; 116: 11-3
https://doi.org/10.1016/j.ijid.2021.12.323

Colombian Ocular Infectious Epidemiology Study (COIES): Herpes Zoster Ophthalmicus prevalence and sociodemographic characterization, 2015-2019
Cifuentes-González et al.
Int J Infect Dis. 2022; 116: 27-33
https://doi.org/10.1016/j.ijid.2021.12.332

Prevalence of diabetes mellitus in patients with tuberculosis: a prospective cohort study
Kiertiburanakul et al.
Int J Infect Dis. 2022; 116: 374-9
https://doi.org/10.1016/j.ijid.2022.01.047

HIV
---
Interaction of sex and HIV infection on renal impairment: baseline evidence from the CHART cohort
Shi et al.
Int J Infect Dis. 2022; 116: 182-8
https://doi.org/10.1016/j.ijid.2022.01.010

HIV incidence and prevalence among adults aged 15-64 years in Rwanda: results from the Rwanda population-based HIV impact assessment (RPHIA) and district-level modeling, 2019
Nsanzimana et al.
Int J Infect Dis. 2022; 116: 245-54
https://doi.org/10.1016/j.ijid.2022.01.032

Screening for hepatocellular carcinoma among adults with HIV/hepatitis B coinfection in Zambia: a pilot study
Riebensahm et al.
Int J Infect Dis. 2022; 116: 391-6
https://doi.org/10.1016/j.ijid.2021.12.338

Parasitic infections
--------------------
Rapid assessment of _Opisthorchis viverrine_ IgG antibody in serum: a potential diagnostic biomarker to predict risk of cholangiocarcinoma in regions endemic for opisthorchiasis
Rodpai et al.
Int J Infect Dis. 2022; 116: 80-4
https://doi.org/10.1016/j.ijid.2021.12.347

Prevalence of and temporal changes in mutations linked to antimalarial drug resistance in _Plasmodium falciparum_ and _Plasmodium vivax_ in Palawan, Philippines
Bareng et al.
Int J Infect Dis. 2022; 116: 174-81
https://doi.org/10.1016/j.ijid.2021.12.318

Vaccines and vaccine preventable infections
-------------------------------------------
The seroprevalence, waning rate, and protective duration of anti-diphtheria toxoid IgG antibody in Nha Trang, Vietnam
Kitamura et al.
Int J Infect Dis. 2022; 116: 273-80
https://doi.org/10.1016/j.ijid.2022.01.025

Public health
-------------
Novel risk factors associated with common vaginal infections: a nationwide primary healthcare cohort study
Jansåker et al.
Int J Infect Dis. 2022; 116: 380-6
https://doi.org/10.1016/j.ijid.2022.01.021

Case reports
------------
Challenging diagnosis of abdominal tuberculosis in children: cases report
Dekeryte et al.
Int J Infect Dis. 2022; 116: 130-2
https://doi.org/10.1016/j.ijid.2021.12.342

Vaccine-induced massive pulmonary embolism and thrombocytopenia following a single dose of Janssen ad26.cov2 vaccination
Curcio et al.
Int J Infect Dis. 2022; 116: 154-6
https://doi.org/10.1016/j.ijid.2021.12.345

Ceftriaxone-associated encephalopathy in a patient with high levels of ceftriaxone in blood and cerebrospinal fluid
Nishioka et al.
Int J Infect Dis. 2022; 116: 223-5
https://doi.org/10.1016/j.ijid.2022.01.023

Rabbit-derived human _Thelazia callipaeda_ infection: a case report
Tian et al.
Int J Infect Dis. 2022; 116: 355-7
https://doi.org/10.1016/j.ijid.2022.01.014

Corrigendum
-----------
Corrigendum to "An automated chemiluminescent immunoassay (CLIA) detects SARS-CoV-2 neutralizing antibody levels in COVID-19 patients and vaccines " [Int J Infect Dis. 2022; 115: 116-25 ISSN 1201-9712]
Liu et al.
Int J Infect Dis. 2022; 116: 426
https://doi.org/10.1016/j.ijid.2022.01.037

--
Communicated by:
ProMED
See Also
New in IJID (02): February 2022 20220206.8701298
New in IJID (01): December 2021 20220109.8700756
2021
----
New in IJID (11): November 2021 20211205.8700079
New in IJID (10): October 2021 20211107.8699506
New in IJID (09): September 2021 20211007.8698901
New in IJID (08): August 2021 20210907.8651803
New in IJID (07): July 2021 20210812.8580841
New in IJID (06): June 2021 20210722.8536790
New in IJID (05): May 2021 20210516.8364910
New in IJID (04): April 2021 20210421.8319851
New in IJID (03): March 2021 20210316.8250191
New in IJID (02): February 2021 20210210.8182520
.................................................ep/rd/mpp
</body>
